Kazia Therapeutics Ltd ADR

Kazia Therapeutics Ltd ADR - Current Ratioverified

KZIA

Price:

$12

Market Cap:

$27.54M

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphoma, diffuse intrinsic pontine glioma, and brain metastases; and in pre-clinical studies to treat triple-negative breast cancer, as well as for the treatment of atypical rhabdoid/teratoid tumors. It als...[Read more]

Industry

Biotechnology

IPO Date

1999-01-06

Stock Exchange

NASDAQ

Ticker

KZIA

The Current Ratio as of August 2026 (TTM) for Kazia Therapeutics Ltd ADR (KZIA) is 2.87

According to Kazia Therapeutics Ltd ADR’s latest financial reports and current stock price. The company's current Current Ratio is 2.87. This represents a change of 213.21% compared to the average of 0.92 of the last 4 quarters.

Kazia Therapeutics Ltd ADR (KZIA) Historical Current Ratio (quarterly & annually)

How has KZIA Current Ratio performed in the past?

The mean historical Current Ratio of Kazia Therapeutics Ltd ADR over the last ten years is 4.23. The current 2.87 Current Ratio has changed 6.69% with respect to the historical average. Over the past ten years (40 quarters), KZIA's Current Ratio was at its highest in in the December 2015 quarter at 27.14. The Current Ratio was at its lowest in in the December 2024 quarter at 0.21.

Quarterly (TTM)
Annual

Average

4.23

Median

2.24

Minimum

0.24

Maximum

23.81

Kazia Therapeutics Ltd ADR (KZIA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kazia Therapeutics Ltd ADR Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 67.89%

Maximum Annual Current Ratio = 23.81

Minimum Annual Increase = -84.80%

Minimum Annual Current Ratio = 0.24

Quarterly (TTM)
Annual
YearCurrent RatioChange
20250.3547.39%
20240.24-83.27%
20231.421.39%
20221.40-60.21%
20213.5367.89%
20202.10-38.49%
20193.4243.47%
20182.38-34.16%
20173.62-84.80%
201623.81-5.23%

Kazia Therapeutics Ltd ADR (KZIA) Average Current Ratio

How has KZIA Current Ratio performed in the past?

The current Current Ratio of Kazia Therapeutics Ltd ADR (KZIA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

0.67

5-year avg

1.39

10-year avg

4.23

Kazia Therapeutics Ltd ADR (KZIA) Current Ratio vs. Peers

How is KZIA’s Current Ratio compared to its peers?

Kazia Therapeutics Ltd ADR’s Current Ratio is less than Can-Fite BioPharma Ltd. (3.46), greater than CNS Pharmaceuticals, Inc. (0.88), less than Silo Pharma, Inc. (9.65), greater than Soligenix, Inc. (1.81), greater than Biodexa Pharmaceuticals Plc (2.03), less than Clearmind Medicine Inc. (4.79), less than InMed Pharmaceuticals Inc. (3.11), less than GRI Bio, Inc. (14.21), less than Oragenics, Inc. (133.42), less than Titan Pharmaceuticals, Inc. (301.55),

Build a custom stock screener for Kazia Therapeutics Ltd ADR (KZIA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kazia Therapeutics Ltd ADR using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kazia Therapeutics Ltd ADR (KZIA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kazia Therapeutics Ltd ADR or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Kazia Therapeutics Ltd ADR's Current Ratio?

How is the Current Ratio calculated for Kazia Therapeutics Ltd ADR (KZIA)?

What is the highest Current Ratio for Kazia Therapeutics Ltd ADR (KZIA)?

What is the 3-year average Current Ratio for Kazia Therapeutics Ltd ADR (KZIA)?

What is the 5-year average Current Ratio for Kazia Therapeutics Ltd ADR (KZIA)?

How does the current Current Ratio for Kazia Therapeutics Ltd ADR (KZIA) compare to its historical average?